Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - SIGMA LABS, INC.v388959_ex99-1.htm

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): September 5, 2014

 

SIGMA LABS, INC.

(Exact name of registrant as specified in its charter)

 

 

Nevada   33-2783-S   82-0404220
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

100 Cienega Street, Suite C

Santa Fe, New Mexico 87501

 

_________________________

 

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (505) 438-2576

 

 

Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 
 

 

Item 8.01 Other Events.

 

The Annual Meeting of stockholders of Sigma Labs, Inc. (the “Company”) will be held on Thursday, October 9, 2014, at 10:00 A.M., local time, at 3900 Paseo del Sol, Santa Fe, New Mexico 87507. Stockholders of record at the close of business on August 25, 2014 will be entitled to vote at the Annual Meeting. A copy of the Company's proxy statement relating to the Annual Meeting, which was mailed to the Company's stockholders beginning on September 5, 2014, is filed with this Current Report on Form 8-K as Exhibit 99. 1.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)Exhibits.

 

Exhibit Number   Description
     
99.1   Proxy Statement of Sigma Labs, Inc.

 

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

        SIGMA LABS, INC.
           
Date: September 11, 2014   By: /s/ Mark Cola
        Name: Mark Cola
        Title: President and Chief Executive  Officer